These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31436377)

  • 1. Cutaneous necrotic lesion: A wonderful delay adverse effect of interferon beta-1b injection for multiple sclerosis treatment.
    Mozafari N; Saffaei A; Alizadeh M; Shabani M
    J Cosmet Dermatol; 2020 Apr; 19(4):951-953. PubMed ID: 31436377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphea secondary to interferon beta1b injection: a case and review of the literature.
    Ozlu E; Karadag AS; Akdeniz N; Uzuncakmak TK; Zemheri E; Ozkanli S
    Dermatol Online J; 2019 Apr; 25(4):. PubMed ID: 31046913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
    Faghihi G; Basiri A; Pourazizi M; Abtahi-Naeini B; Saffaei A
    J Res Pharm Pract; 2015; 4(2):99-103. PubMed ID: 25984549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed occurrence of a severe cutaneous reaction in a multiple sclerosis patient taking interferon beta-1b.
    Cohen BA; Greenberger PA; Saini S
    Allergy Asthma Proc; 1998; 19(2):85-8. PubMed ID: 9578917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis.
    Inafuku H; Kasem Khan MA; Nagata T; Nonaka S
    J Dermatol; 2004 Aug; 31(8):671-7. PubMed ID: 15492442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus-like reaction to interferon at the injection site: report of five cases.
    Arrue I; Saiz A; Ortiz-Romero PL; Rodríguez-Peralto JL
    J Cutan Pathol; 2007 Dec; 34 Suppl 1():18-21. PubMed ID: 17997732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon-beta injection].
    Ziegler VR; Kränke B; Soyer P; Aberer W
    Hautarzt; 1998 Apr; 49(4):310-2. PubMed ID: 9606633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.
    García-F-Villalta M; Daudén E; Sánchez J; Fraga J; Ramo C; García-Díez A
    Acta Derm Venereol; 2001 May; 81(2):152. PubMed ID: 11501663
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute acneiform eruption induced by interferon beta-1b during treatment for multiple sclerosis.
    Rosa DJ; Matias Fde A; Cedrim SD; Machado RF; Sá AA; Silva VC
    An Bras Dermatol; 2011; 86(2):336-8. PubMed ID: 21603818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed drug eruption with interferon-beta-1b.
    Tai YJ; Tam M
    Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis.
    Marziniak M; Meuth S
    Adv Ther; 2014 Sep; 31(9):915-31. PubMed ID: 25182864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum.
    Elgart GW; Sheremata W; Ahn YS
    J Am Acad Dermatol; 1997 Oct; 37(4):553-8. PubMed ID: 9344192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin necrosis following a recombinant interferon-beta-1b injection.
    Yang CH; Chen CH; Chan HL
    Chang Gung Med J; 2002 Nov; 25(11):774-7. PubMed ID: 12553367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
    Zettl UK; Bauer-Steinhusen U; Glaser T; Czekalla J; Hechenbichler K; Limmroth V; Hecker M
    Adv Ther; 2016 May; 33(5):834-47. PubMed ID: 27090116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vasculitis associated with interferon beta-1b treatment for multiple sclerosis.
    Szilasiová J; Gdovinová Z; Jautová J; Baloghová J; Ficová M; Bohus P
    Clin Neuropharmacol; 2009; 32(5):301-3. PubMed ID: 19820436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma-induced local leukocytoclastic vasculitis at the subcutaneous injection site.
    Wang F; Liu JH; Zhao YK; Luo DQ
    An Bras Dermatol; 2016; 91(5 suppl 1):76-78. PubMed ID: 28300901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous adverse events induced by azacitidine in myelodysplastic syndrome patients: Case reports and a lesson from published work review.
    Shimoda-Komatsu Y; Mizukawa Y; Takayama N; Ohyama M
    J Dermatol; 2020 Apr; 47(4):363-368. PubMed ID: 32056290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized inflammatory reactions at sites of subcutaneous methotrexate injections during treatment with ultraviolet B.
    Muthiah S; Charlton F; Farr PM
    Br J Dermatol; 2018 Jul; 179(1):192-194. PubMed ID: 29341063
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
    Mazzon E; Guarneri C; Giacoppo S; Rifici C; Tchernev G; Polimeni G; Wollina U
    Int J Immunopathol Pharmacol; 2014; 27(4):669-74. PubMed ID: 25572749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.